BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11567659)

  • 21. Glycyrrhizic acid attenuates the expression of HMG-CoA reductase mRNA in high fructose diet induced dyslipidemic hamsters.
    Maurya SK; Srivastava AK
    Prague Med Rep; 2011; 112(1):29-37. PubMed ID: 21470496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.
    Minnich A; Tian N; Byan L; Bilder G
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E270-9. PubMed ID: 11158930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice.
    Jeong S; Yoon M
    Exp Mol Med; 2009 Jun; 41(6):397-405. PubMed ID: 19322024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
    Chakrabarti R; Vikramadithyan RK; Misra P; Hiriyan J; Raichur S; Damarla RK; Gershome C; Suresh J; Rajagopalan R
    Br J Pharmacol; 2003 Oct; 140(3):527-37. PubMed ID: 12970088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effects of fenofibrate on insulin resistance, hyperglycaemia, visceral fat accumulation in NIH mice induced by small-dose streptozotocin and lard.
    Xie W; Nie Y; Du L; Zhang Y; Cai G
    Pharmacol Res; 2007 May; 55(5):392-9. PubMed ID: 17306985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism.
    Zhao MJ; Wang SS; Jiang Y; Wang Y; Shen H; Xu P; Xiang H; Xiao H
    Lipids Health Dis; 2017 May; 16(1):85. PubMed ID: 28464894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM
    J Diabetes Complications; 2014; 28(3):323-7. PubMed ID: 24560135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.
    Eu CH; Lim WY; Ton SH; bin Abdul Kadir K
    Lipids Health Dis; 2010 Jul; 9():81. PubMed ID: 20670429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of anti-atherosclerotic activities of PPAR-α, PPAR-γ, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F(1)B hamsters.
    Srivastava RA
    Atherosclerosis; 2011 Jan; 214(1):86-93. PubMed ID: 21093860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
    Tsunoda M; Kobayashi N; Ide T; Utsumi M; Nagasawa M; Murakami K
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E833-40. PubMed ID: 18212024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.
    Bennett AJ; Billett MA; Salter AM; Mangiapane EH; Bruce JS; Anderton KL; Marenah CB; Lawson N; White DA
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):167-73. PubMed ID: 7575449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
    Jeong S; Han M; Lee H; Kim M; Kim J; Nicol CJ; Kim BH; Choi JH; Nam KH; Oh GT; Yoon M
    Metabolism; 2004 Oct; 53(10):1284-9. PubMed ID: 15375783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats.
    Maruyama S; Kato K; Kodama M; Hirono S; Fuse K; Nakagawa O; Nakazawa M; Miida T; Yamamoto T; Watanabe K; Aizawa Y
    J Atheroscler Thromb; 2002; 9(2):87-92. PubMed ID: 12236317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
    Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
    Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients.
    Forcheron F; Cachefo A; Thevenon S; Pinteur C; Beylot M
    Diabetes; 2002 Dec; 51(12):3486-91. PubMed ID: 12453904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway.
    Edgar AD; Tomkiewicz C; Costet P; Legendre C; Aggerbeck M; Bouguet J; Staels B; Guyomard C; Pineau T; Barouki R
    Toxicol Lett; 1998 Sep; 98(1-2):13-23. PubMed ID: 9776557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.